Sarepta Therapeutics Inc (SRPT)
Receivables turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 1,243,340 | 933,013 | 701,887 | 540,099 | 380,833 |
Receivables | US$ in thousands | 403,058 | 217,939 | 152,990 | 101,340 | 90,879 |
Receivables turnover | 3.08 | 4.28 | 4.59 | 5.33 | 4.19 |
December 31, 2023 calculation
Receivables turnover = Revenue ÷ Receivables
= $1,243,340K ÷ $403,058K
= 3.08
Sarepta Therapeutics Inc's receivables turnover has been variable over the past five years. The trend indicates a decrease in efficiency in collecting receivables from customers. The company's receivables turnover ratio decreased from 4.19 in 2019 to 3.08 in 2023. This suggests that it took longer for Sarepta Therapeutics Inc to collect payments from customers in 2023 compared to previous years. A lower receivables turnover ratio may indicate potential issues with credit policies, collection efforts, or the creditworthiness of customers. It is important for the company to monitor and improve its receivables turnover to ensure the efficient management of its accounts receivable and cash flow.
Peer comparison
Dec 31, 2023